5-Bromo-1-propyl-1H-benzo[d]imidazole hydrochloride

Catalog No.: 
ACKUFE501
CAS No.: 
1199773-13-1
Molecular Formula: 
C10H12BrClN2
Molecular Weight: 
275.58
5-Bromo-1-propyl-1H-benzo[d]imidazole hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$68.00InquiryInquiry
5g98%$203.00InquiryInquiry
25g98%$647.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1-propyl-1H-benzo[d]imidazole hydrochloride
IUPAC Name5-bromo-1-propyl-1H-benzo[d]imidazole hydrochloride
MDL No.MFCD13195718
Molecular FormulaC10H12BrClN2
Molecular Weight275.58
SMILESCCCN1C=NC2=CC(Br)=CC=C12.[H]Cl
InChI KeyXOFBBZYKXVDVKS-UHFFFAOYSA-N
Synonym5-Bromo-1-propyl-benzoimidazole HCl;5-bromo-1-propyl-1H-benzo[d]imidazole hydrochloride;1H-Benzimidazole, 5-bromo-1-propyl-, hydrochloride (1:1);5-Bromo-1-propyl-benzoimidazole hydrochloride
CAS No.1199773-13-1

Synthetic Route by SureRoute

1. ACKUFE501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHWJL206 route compound structure diagram
    ACHWJL2064887-88-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKUFE501 route product structure diagram
    ACKUFE5011199773-13-1
Inquiry

2. ACKUFE501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2In Stock
  4. Then
  5. ACKUFE501 route product structure diagram
    ACKUFE5011199773-13-1
Inquiry

3. ACKUFE501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHWJL206 route compound structure diagram
    ACHWJL2064887-88-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKUFE501 route product structure diagram
    ACKUFE5011199773-13-1
Inquiry

Comments (0)